TY - JOUR
T1 - Expression of the embryonic morphogen Nodal in cutaneous melanocytic lesions
AU - Yu, Limin
AU - Harms, Paul W.
AU - Pouryazdanparast, Pedram
AU - Kim, David S.L.
AU - Ma, Linglei
AU - Fullen, Douglas R.
PY - 2010/9
Y1 - 2010/9
N2 - Nodal, a potent embryonic morphogen in the transforming growth factor-Β family, is a proposed key regulator of melanoma tumorigenicity. However, there has been no systematic study of Nodal expression in melanocytic lesions. We investigated Nodal expression by immunohistochemistry in 269 melanocytic lesions, including compound nevi, dysplastic nevi, congenital nevi, Spitz nevi, melanoma in situ, malignant melanoma including the variant desmoplastic melanoma, and metastatic melanoma. We found that the Nodal expression was significantly increased in malignant lesions (including melanoma in situ, malignant melanoma, and metastatic melanoma) compared with compound nevi, Spitz nevi, and dysplastic nevi. Surprisingly, congenital nevi expressed a level of Nodal comparable with malignant lesions, whereas desmoplastic melanoma showed lower expression than nondesmoplastic malignant melanoma (P0.05). Deep melanoma (Breslow depth 1 mm) displayed a higher percentage of Nodal-positive tumor cells than did superficial melanoma (Breslow depth 1 mm), although there was no statistical difference in the overall staining intensity (P0.18). Melanomas in situ showed a lower level of Nodal expression than did deep melanomas and metastatic melanomas (P0.05). The low expression of Nodal in normal and dysplastic nevi, and its increasing expression with the progression of malignant lesions, are suggestive of a role for Nodal in melanoma progression.
AB - Nodal, a potent embryonic morphogen in the transforming growth factor-Β family, is a proposed key regulator of melanoma tumorigenicity. However, there has been no systematic study of Nodal expression in melanocytic lesions. We investigated Nodal expression by immunohistochemistry in 269 melanocytic lesions, including compound nevi, dysplastic nevi, congenital nevi, Spitz nevi, melanoma in situ, malignant melanoma including the variant desmoplastic melanoma, and metastatic melanoma. We found that the Nodal expression was significantly increased in malignant lesions (including melanoma in situ, malignant melanoma, and metastatic melanoma) compared with compound nevi, Spitz nevi, and dysplastic nevi. Surprisingly, congenital nevi expressed a level of Nodal comparable with malignant lesions, whereas desmoplastic melanoma showed lower expression than nondesmoplastic malignant melanoma (P0.05). Deep melanoma (Breslow depth 1 mm) displayed a higher percentage of Nodal-positive tumor cells than did superficial melanoma (Breslow depth 1 mm), although there was no statistical difference in the overall staining intensity (P0.18). Melanomas in situ showed a lower level of Nodal expression than did deep melanomas and metastatic melanomas (P0.05). The low expression of Nodal in normal and dysplastic nevi, and its increasing expression with the progression of malignant lesions, are suggestive of a role for Nodal in melanoma progression.
UR - http://www.scopus.com/inward/record.url?scp=77956283187&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77956283187&partnerID=8YFLogxK
U2 - 10.1038/modpathol.2010.101
DO - 10.1038/modpathol.2010.101
M3 - Article
C2 - 20495543
AN - SCOPUS:77956283187
SN - 0893-3952
VL - 23
SP - 1209
EP - 1214
JO - Modern Pathology
JF - Modern Pathology
IS - 9
ER -